GT-4003

N/A

Report date: 2023/02/11 20:38:33

Base Information

Drug NameGT-4003

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionBeta amyloid A4 protein inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGliatech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGliatech

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A